Researchers at Children's Hospital of Philadelphia (CHOP) identified a potential new therapeutic target for eosinophilic ...

Esophagitis is inflammation of the esophagus, the tube that carries food from your mouth to your stomach, and can be caused by various factors including acid reflux, infections, and immune reactions.

A New Drug Application for the EE and NERD indications for tegoprazan will be submitted in the fourth quarter of 2025. Topline data were announced from the maintenance phase of a phase 3 trial ...

Eosinophilic esophagitis (EoE) is a condition that affects the esophagus, which is the tube through which food travels from your throat to your stomach. In EoE, white blood cells called eosinophils ...

Gastroesophageal reflux disease (GERD) is one of the most common disorders of the gastrointestinal tract, with a pooled prevalence of 21% in the U.S., accounting for more than 4.6 million ambulatory ...

If you feel like you’ve hit a treatment wall with proton pump inhibitors (PPIs), here's why your EoE symptoms may still be ...

If you have a new diagnosis of eosinophilic esophagitis (EoE), you’ll want to know what the best treatment is for you. The mainstays of treatment for EoE are proton pump inhibitors, steroids, diet ...

Eosinophilic esophagitis (EoE) causes inflammation and swelling in your esophagus. It shouldn't change the length of your life, but it could affect your quality of life. Over time, EoE can leave ...

The FDA approved vonoprazan (Voquezna) for all grades of erosive gastroesophageal reflux disease (GERD) and heartburn relief associated with the condition, Phathom Pharmaceuticals announced on ...